Top Story

New studies evaluate Jardiance in patients with chronic heart failure

April 30, 2016

Two new outcome trials will investigate the SGLT2 inhibitor Jardiance for the treatment of people with chronic heart failure, Boehringer Ingelheim and Eli Lilly and Company said in a joint press release.

The trials are slated to begin in the next 12 months and are planned to enroll people with chronic heart failure both with and without type 2 diabetes.

In the Journals

Later onset, longer duration of Graves’ hyperthyroidism, smoking predictors for Graves’ orbitopathy

April 29, 2016
In patients with Graves’ hyperthyroidism, predictive factors for Graves’ orbitopathy include older age of disease onset, longer disease duration and smoking…
In the Journals

Urinary incontinence associated with type 1 diabetes in women

April 29, 2016
The odds of urinary incontinence increase with poor glycemic control in women with type 1 diabetes, according to recent study findings. Sara M. Lenherr, MD
In the Journals

Psoriasis associated with type 2 diabetes, obesity in twin study

April 29, 2016
Psoriasis had a strong association with type 2 diabetes and obesity in a nationwide study of Danish twins, indicating a common genetic etiology between psoriasis and…
In the Journals

ACP: Physicians can help tackle public health threat of climate change

April 29, 2016
Climate change poses a significant threat to public health and needs to be addressed by drastic actions in part by physicians and the health care community, according to…
More News Headlines »

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Meeting News Coverage

VIDEO: Testosterone Trials results announcement met with anticipation

April 7, 2016
More »
Highlights from ENDO 2016

Highlights from ENDO 2016

CME Video

Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes…
More »
Current Issues
View the Current Issues